RU2646826C2 - Контейнер с концентрированным веществом и способ его применения - Google Patents

Контейнер с концентрированным веществом и способ его применения Download PDF

Info

Publication number
RU2646826C2
RU2646826C2 RU2015111256A RU2015111256A RU2646826C2 RU 2646826 C2 RU2646826 C2 RU 2646826C2 RU 2015111256 A RU2015111256 A RU 2015111256A RU 2015111256 A RU2015111256 A RU 2015111256A RU 2646826 C2 RU2646826 C2 RU 2646826C2
Authority
RU
Russia
Prior art keywords
container body
concentrated
contrast agent
volume
liquid
Prior art date
Application number
RU2015111256A
Other languages
English (en)
Russian (ru)
Other versions
RU2015111256A (ru
Inventor
Скотт Уэйн ХОЛЛАНДЕР
Джоэл Роберт ТИМБЕРЛЕЙК
Марджори КАДАШ
Original Assignee
Оцука Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Оцука Фармасьютикал Ко., Лтд. filed Critical Оцука Фармасьютикал Ко., Лтд.
Publication of RU2015111256A publication Critical patent/RU2015111256A/ru
Application granted granted Critical
Publication of RU2646826C2 publication Critical patent/RU2646826C2/ru

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/54—Inspection openings or windows
    • B65D25/56—Inspection openings or windows with means for indicating level of contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0046—Cups, bottles or bags
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A61K49/105—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA the metal complex being Gd-DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A61K49/108—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
    • B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
    • B65D85/816—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package into which liquid is added and the resulting preparation is retained, e.g. cups preloaded with powder or dehydrated food
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F19/00—Calibrated capacity measures for fluids or fluent solid material, e.g. measuring cups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
RU2015111256A 2012-08-30 2013-08-30 Контейнер с концентрированным веществом и способ его применения RU2646826C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/599,045 US20140065076A1 (en) 2012-08-30 2012-08-30 Container with concentrated substance and method of using the same
US13/599,045 2012-08-30
PCT/US2013/057529 WO2014036402A1 (en) 2012-08-30 2013-08-30 Container with concentrated substance and method of using the same

Publications (2)

Publication Number Publication Date
RU2015111256A RU2015111256A (ru) 2016-10-20
RU2646826C2 true RU2646826C2 (ru) 2018-03-07

Family

ID=49209541

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015111256A RU2646826C2 (ru) 2012-08-30 2013-08-30 Контейнер с концентрированным веществом и способ его применения

Country Status (8)

Country Link
US (2) US20140065076A1 (enExample)
EP (1) EP2890354B1 (enExample)
JP (1) JP6116691B2 (enExample)
CA (1) CA2883391C (enExample)
ES (1) ES2592705T3 (enExample)
RU (1) RU2646826C2 (enExample)
TW (1) TWI581787B (enExample)
WO (1) WO2014036402A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2715386C1 (ru) * 2019-04-26 2020-02-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) Упаковка для мягкой лекарственной формы индивидуального изготовления

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2940698A1 (en) 2014-03-04 2015-09-11 Otsuka Pharmaceutical Co., Ltd. Iohexol powder and method of using the same
US20160060022A1 (en) * 2014-08-27 2016-03-03 John Frank Stagl Apparatus for providing cocktail mix
US11090130B2 (en) * 2015-10-09 2021-08-17 Oregon State University Fiducial marker for computed tomography and magnetic resonance imaging
GB201703227D0 (en) * 2017-01-20 2017-04-12 Ge Healthcare As Plastic containers
US10947012B1 (en) * 2019-04-23 2021-03-16 Express Scripts Strategic Development, Inc. Container with fill gauge
AU2020289560A1 (en) 2019-06-05 2021-12-23 Emory University Peptidomimetics for the treatment of coronavirus and picornavirus infections
JP7444554B2 (ja) * 2019-06-21 2024-03-06 大和製罐株式会社 難溶性飲料製品
CN110559188A (zh) * 2019-09-17 2019-12-13 长沙凯泽工程设计有限公司 一种药物提取装置
KR102523963B1 (ko) * 2020-01-03 2023-04-21 이화여자대학교 산학협력단 이종 약물을 혼합하기 위한 안약 용기
JP1698881S (enExample) 2020-05-15 2021-11-08
GB2601578A (en) * 2020-05-15 2022-06-08 Procter & Gamble Refillable product containing dissolvable solid article
CA3117023A1 (en) * 2020-05-15 2021-11-15 The Procter & Gamble Company Product containing dissolvable solid article
WO2021236322A1 (en) * 2020-05-19 2021-11-25 Exxonmobil Chemical Patents Inc. Extrusion blow molded containers and processes for making same
CA3191875A1 (en) 2020-09-10 2022-03-17 Ian-Ling Lim Dissolvable solid article containing anti-bacterial actives
EP4281029A1 (en) 2021-01-21 2023-11-29 The Procter & Gamble Company Dissolvable solid article containing preservatives
CN113069129B (zh) * 2021-02-26 2023-04-11 四川省肿瘤医院 一种18f-fdg pet/ct检查去除胃内伪影的方法
CA3227354A1 (en) 2021-08-20 2023-02-23 The Procter & Gamble Company Dissolvable solid article containing silicone

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023495A (en) * 1963-03-25 1966-03-23 Nyegaard & Co As X-ray contrast media
FR2298840A1 (fr) * 1975-01-22 1976-08-20 Beaudoux Maurice Etiquette pour recipient transparent ou translucide contenant un produit a doser
EP0255493A2 (en) * 1986-07-15 1988-02-03 Fausto Gallina Container for the simultaneous administration of barium sulphate suspension and air in the double contrast x-ray examination of the upper digestive tract
US5532269A (en) * 1993-10-11 1996-07-02 Asta Medica Aktiengesellschaft Preparation for treating circulatory changes
SK278621B6 (en) * 1990-09-14 1997-11-05 Torsten Almen The contrasting agent
US5847212A (en) * 1997-04-21 1998-12-08 Abbott Laboratories Process for the preparation of iohexol
CN1704068A (zh) * 2004-05-27 2005-12-07 姜叶东 治疗心脏病的药物及其制备方法
US20050284302A1 (en) * 2002-08-08 2005-12-29 Concept & Design Ltd. Portable beverage preparation device and system
US20060178533A1 (en) * 2003-07-03 2006-08-10 Holmaas Lars T Process for iohexol manufacture
GB2435027A (en) * 2006-02-08 2007-08-15 Shurbhi Shah Container for use in administering medicine
MY132225A (en) * 1995-03-13 2007-09-28 Amersham Health Inc Contrast agent for ultrasonography
US20080044314A1 (en) * 2006-06-23 2008-02-21 Cephalon, Inc. Pharmaceutical measuring and dispensing cup
WO2008048074A1 (en) * 2006-10-20 2008-04-24 Seoul National University Industry Foundation Use of core-shell gold nanoparticle which contains magnetic nanoparticles for mri t2 contrast agent, cancer diagnostic and therapy
US20090143471A1 (en) * 2006-04-07 2009-06-04 Guerbet Process for the Atomization of Ioxilan
KR20090119324A (ko) * 2008-05-16 2009-11-19 한남대학교 산학협력단 금-증착된 산화철/글리콜 키토산 나노복합체, 이의제조방법 및 이를 포함하는 ｍｒｉ 조영제
WO2011122639A1 (ja) * 2010-03-29 2011-10-06 株式会社モリモト医薬 経口摂取用の医薬組成物容器
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
CN202223624U (zh) * 2011-08-31 2012-05-23 郑培省 调压洗肠器
CN102580120A (zh) * 2012-03-21 2012-07-18 海南医学院附属医院 一种靶向性mri对比剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0674213B2 (ja) * 1988-07-05 1994-09-21 マナック株式会社 消化管用固形ｘ線造影剤
JPH02261801A (ja) * 1989-04-03 1990-10-24 Tetsuo Suami 低粘度ヨード化ヒドロキシエチル澱粉およびその製法
JPH0734816B2 (ja) * 1991-06-26 1995-04-19 新田ゼラチン株式会社 医科用および歯科用硬化性材料
JP3559966B2 (ja) * 2001-07-11 2004-09-02 堀井薬品工業株式会社 注腸造影法に用いる造影剤容器
US7674434B2 (en) * 2006-11-27 2010-03-09 Cytyc Corporation Vials and apparatus for obtaining an aliquot of a sample
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
US9403624B2 (en) * 2009-08-24 2016-08-02 Beekley Corporation Device and method for dispensing a beverage and imaging contrast agent

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023495A (en) * 1963-03-25 1966-03-23 Nyegaard & Co As X-ray contrast media
FR2298840A1 (fr) * 1975-01-22 1976-08-20 Beaudoux Maurice Etiquette pour recipient transparent ou translucide contenant un produit a doser
EP0255493A2 (en) * 1986-07-15 1988-02-03 Fausto Gallina Container for the simultaneous administration of barium sulphate suspension and air in the double contrast x-ray examination of the upper digestive tract
SK278621B6 (en) * 1990-09-14 1997-11-05 Torsten Almen The contrasting agent
US5532269A (en) * 1993-10-11 1996-07-02 Asta Medica Aktiengesellschaft Preparation for treating circulatory changes
MY132225A (en) * 1995-03-13 2007-09-28 Amersham Health Inc Contrast agent for ultrasonography
US5847212A (en) * 1997-04-21 1998-12-08 Abbott Laboratories Process for the preparation of iohexol
US20050284302A1 (en) * 2002-08-08 2005-12-29 Concept & Design Ltd. Portable beverage preparation device and system
US20060178533A1 (en) * 2003-07-03 2006-08-10 Holmaas Lars T Process for iohexol manufacture
CN1704068A (zh) * 2004-05-27 2005-12-07 姜叶东 治疗心脏病的药物及其制备方法
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB2435027A (en) * 2006-02-08 2007-08-15 Shurbhi Shah Container for use in administering medicine
US20090143471A1 (en) * 2006-04-07 2009-06-04 Guerbet Process for the Atomization of Ioxilan
US20080044314A1 (en) * 2006-06-23 2008-02-21 Cephalon, Inc. Pharmaceutical measuring and dispensing cup
WO2008048074A1 (en) * 2006-10-20 2008-04-24 Seoul National University Industry Foundation Use of core-shell gold nanoparticle which contains magnetic nanoparticles for mri t2 contrast agent, cancer diagnostic and therapy
KR20090119324A (ko) * 2008-05-16 2009-11-19 한남대학교 산학협력단 금-증착된 산화철/글리콜 키토산 나노복합체, 이의제조방법 및 이를 포함하는 ｍｒｉ 조영제
WO2011122639A1 (ja) * 2010-03-29 2011-10-06 株式会社モリモト医薬 経口摂取用の医薬組成物容器
CN202223624U (zh) * 2011-08-31 2012-05-23 郑培省 调压洗肠器
CN102580120A (zh) * 2012-03-21 2012-07-18 海南医学院附属医院 一种靶向性mri对比剂及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2715386C1 (ru) * 2019-04-26 2020-02-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) Упаковка для мягкой лекарственной формы индивидуального изготовления

Also Published As

Publication number Publication date
ES2592705T3 (es) 2016-12-01
TWI581787B (zh) 2017-05-11
US20140065077A1 (en) 2014-03-06
EP2890354B1 (en) 2016-07-20
CA2883391A1 (en) 2014-03-06
US20140065076A1 (en) 2014-03-06
JP6116691B2 (ja) 2017-04-19
JP2015528351A (ja) 2015-09-28
TW201410232A (zh) 2014-03-16
CA2883391C (en) 2020-12-29
EP2890354A1 (en) 2015-07-08
RU2015111256A (ru) 2016-10-20
WO2014036402A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
EP2890354B1 (en) Container with concentrated substance and method of using the same
US11975020B2 (en) Colon lavage system
KR102257207B1 (ko) Peg 및 아스코르베이트를 포함하는 조성물
CN105963701A (zh) 用于肠道清洁的方法、组合物以及包装
EP2626085A1 (en) Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging digestive tract
JP6441678B2 (ja) Ｃｔコロノグラフィに用いられる経口投与用液剤及び消化管造影用組成物
US20130052143A1 (en) Liquid preparation for oral administration to be used in ct colonography, and composition for digestive tract imaging
JP2013060441A (ja) Ｃｔコロノグラフィに用いられる経口投与用液剤及び消化管造影用製剤
HK1167572A (en) Colon lavage system
HK1167572B (en) Colon lavage system
HK1206604B (en) Compositions comprising peg and ascorbate